Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shannon T Bailey

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Nature Immunology|September 24, 2005
'PPAR'ting ways with inflammationShannon T Bailey, Sankar Ghosh
Cancer Research|November 13, 2014
Loss of estrogen-regulated microRNA expression increases HER2 signaling and is prognostic of poor outcome in luminal breast cancerShannon T Bailey, Thomas Westerling, Myles Brown
Journal of Cell Science|July 15, 2004
Cytosolic, nuclear and nucleolar localization signals determine subcellular distribution and activity of the NF-kappaB inducing kinase NIKAndreas Birbach, Shannon T Bailey, Sankar Ghosh, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 19, 2012
Estrogen receptor prevents p53-dependent apoptosis in breast cancerShannon T Bailey, Hyunjin Shin, Thomas Westerling, et al.
Molecular Cancer Therapeutics|July 11, 2007
Nuclear factor-kappaB activation: a molecular therapeutic target for estrogen receptor-negative and epidermal growth factor receptor family receptor-positive human breast cancerSindhu Singh, Qian Shi, Shannon T Bailey, et al.
Cancer Cell|July 12, 2011
Targeting androgen receptor in estrogen receptor-negative breast cancerMin Ni, Yiwen Chen, Elgene Lim, et al.
Genes & Development|October 5, 2010
Growth factor stimulation induces a distinct ER(alpha) cistrome underlying breast cancer endocrine resistanceMathieu Lupien, Clifford A Meyer, Shannon T Bailey, et al.
Genes & Development|November 2, 2005
TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivoJae-Hyuck Shim, Changchun Xiao, Amber E Paschal, et al.
Molecular Cancer Research : MCR|December 10, 2013
NF-κB activation-induced anti-apoptosis renders HER2-positive cells drug resistant and accelerates tumor growthShannon T Bailey, Penelope L Miron, Yoon J Choi, et al.
Nature Genetics|March 9, 2010
Nucleosome dynamics define transcriptional enhancersHousheng Hansen He, Clifford A Meyer, Hyunjin Shin, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Nature Immunology|September 24, 2005
'PPAR'ting ways with inflammationShannon T Bailey, Sankar Ghosh
Cancer Research|November 13, 2014
Loss of estrogen-regulated microRNA expression increases HER2 signaling and is prognostic of poor outcome in luminal breast cancerShannon T Bailey, Thomas Westerling, Myles Brown
Journal of Cell Science|July 15, 2004
Cytosolic, nuclear and nucleolar localization signals determine subcellular distribution and activity of the NF-kappaB inducing kinase NIKAndreas Birbach, Shannon T Bailey, Sankar Ghosh, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 19, 2012
Estrogen receptor prevents p53-dependent apoptosis in breast cancerShannon T Bailey, Hyunjin Shin, Thomas Westerling, et al.
Molecular Cancer Therapeutics|July 11, 2007
Nuclear factor-kappaB activation: a molecular therapeutic target for estrogen receptor-negative and epidermal growth factor receptor family receptor-positive human breast cancerSindhu Singh, Qian Shi, Shannon T Bailey, et al.
Cancer Cell|July 12, 2011
Targeting androgen receptor in estrogen receptor-negative breast cancerMin Ni, Yiwen Chen, Elgene Lim, et al.
Genes & Development|October 5, 2010
Growth factor stimulation induces a distinct ER(alpha) cistrome underlying breast cancer endocrine resistanceMathieu Lupien, Clifford A Meyer, Shannon T Bailey, et al.
Genes & Development|November 2, 2005
TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivoJae-Hyuck Shim, Changchun Xiao, Amber E Paschal, et al.
Molecular Cancer Research : MCR|December 10, 2013
NF-κB activation-induced anti-apoptosis renders HER2-positive cells drug resistant and accelerates tumor growthShannon T Bailey, Penelope L Miron, Yoon J Choi, et al.
Nature Genetics|March 9, 2010
Nucleosome dynamics define transcriptional enhancersHousheng Hansen He, Clifford A Meyer, Hyunjin Shin, et al.
Pageof 2